Quarterly report · Q2

Period2023-04-01 → 2023-09-30
Filed2023-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 48
MetricValuePeriodScopeSource row
Revenue¥371.7bn2023-04-01 → 2023-09-30Cons.Net sales
Revenue¥690.5bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥339.2bn2022-04-01 → 2022-09-30Cons.Net sales
Operating income¥20.6bn2023-04-01 → 2023-09-30Cons.Operating income
Operating income¥18.5bn2022-04-01 → 2022-09-30Cons.Operating income
Ordinary income¥21.0bn2023-04-01 → 2023-09-30Cons.Ordinary income
Ordinary income¥38.1bn2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥18.8bn2022-04-01 → 2022-09-30Cons.Ordinary income
Profit before tax¥20.6bn2023-04-01 → 2023-09-30Cons.Income before income taxes
Profit before tax¥18.5bn2022-04-01 → 2022-09-30Cons.Income before income taxes
Net income (owners)¥14.1bn2023-04-01 → 2023-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥25.7bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥12.7bn2022-04-01 → 2022-09-30Cons.Profit loss attributable to owners of parent
Net income¥14.1bn2023-04-01 → 2023-09-30Cons.Profit loss
Net income¥12.7bn2022-04-01 → 2022-09-30Cons.Profit loss
Total assets¥369.9bnat 2023-09-30Cons.Assets
Total assets¥360.7bnat 2023-03-31Cons.Assets
Total assets¥337.1bnat 2022-09-30Cons.Total assets (5-year summary)
Total liabilities¥125.2bnat 2023-09-30Cons.Liabilities
Total liabilities¥124.3bnat 2023-03-31Cons.Liabilities
Net assets / equity¥244.7bnat 2023-09-30Cons.Net assets
Net assets / equity¥236.3bnat 2023-03-31Cons.Net assets
Net assets / equity¥229.1bnat 2022-09-30Cons.Net assets (5-year summary)
Cash and deposits¥76.8bnat 2023-09-30Cons.Cash and deposits
Cash and deposits¥80.9bnat 2023-03-31Cons.Cash and deposits
Cash & equivalents¥76.8bnat 2023-09-30Cons.Cash and cash equivalents
Cash & equivalents¥80.9bnat 2023-03-31Cons.Cash and cash equivalents
Cash & equivalents¥94.5bnat 2022-09-30Cons.Cash and cash equivalents
Cash & equivalents¥89.3bnat 2022-03-31dCons.Cash and cash equivalents
Operating cash flow¥23.4bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥37.4bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥21.4bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥21.7bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥28.5bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥12.0bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥5.8bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥17.3bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥4.2bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥120.22023-04-01 → 2023-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥61.182023-07-01 → 2023-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥219.832022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥108.812022-04-01 → 2022-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥54.942022-07-01 → 2022-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥219.822022-04-01 → 2023-03-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥108.812022-04-01 → 2022-09-30Cons.Diluted earnings per share (5-year summary)
Equity ratio66.1%at 2023-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio65.5%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio68.0%at 2022-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 28
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2023-04-01 → 2023-09-30−¥26.1bn
Reconciling Itemsreconcilingrevenue intersegment2023-04-01 → 2023-09-30−¥26.1bn
jpcrp040300-q2r_E03226-000Discount Storereportable segmentrevenue2023-04-01 → 2023-09-30¥155.0bn
jpcrp040300-q2r_E03226-000Discount Storereportable segmentrevenue external2023-04-01 → 2023-09-30¥155.0bn
jpcrp040300-q2r_E03226-000Discount Storereportable segmentrevenue intersegment2023-04-01 → 2023-09-30¥5m
jpcrp040300-q2r_E03226-000Discount Storereportable segmentsegment profit2023-04-01 → 2023-09-30¥7.5bn
jpcrp040300-q2r_E03226-000Drug Storereportable segmentrevenue2023-04-01 → 2023-09-30¥242.8bn
jpcrp040300-q2r_E03226-000Drug Storereportable segmentrevenue external2023-04-01 → 2023-09-30¥216.7bn
jpcrp040300-q2r_E03226-000Drug Storereportable segmentrevenue intersegment2023-04-01 → 2023-09-30¥26.1bn
jpcrp040300-q2r_E03226-000Drug Storereportable segmentsegment profit2023-04-01 → 2023-09-30¥13.1bn
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2023-09-30¥397.8bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2023-09-30¥371.7bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-04-01 → 2023-09-30¥26.1bn
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2023-09-30¥20.6bn
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-09-30−¥24.7bn
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-09-30−¥24.7bn
jpcrp040300-q2r_E03226-000Discount Storereportable segmentrevenue2022-04-01 → 2022-09-30¥143.9bn
jpcrp040300-q2r_E03226-000Discount Storereportable segmentrevenue external2022-04-01 → 2022-09-30¥143.9bn
jpcrp040300-q2r_E03226-000Discount Storereportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥5m
jpcrp040300-q2r_E03226-000Discount Storereportable segmentsegment profit2022-04-01 → 2022-09-30¥6.7bn
jpcrp040300-q2r_E03226-000Drug Storereportable segmentrevenue2022-04-01 → 2022-09-30¥220.0bn
jpcrp040300-q2r_E03226-000Drug Storereportable segmentrevenue external2022-04-01 → 2022-09-30¥195.3bn
jpcrp040300-q2r_E03226-000Drug Storereportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥24.7bn
jpcrp040300-q2r_E03226-000Drug Storereportable segmentsegment profit2022-04-01 → 2022-09-30¥11.8bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-09-30¥363.9bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-09-30¥339.2bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-09-30¥24.7bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-09-30¥18.5bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 479
ItemContextValueUnit
Number of shares heldCurrentQuarterInstant_No1MajorShareholdersMember43776000
Shareholding ratioCurrentQuarterInstant_No1MajorShareholdersMember0.3743
Number of shares heldCurrentQuarterInstant_No2MajorShareholdersMember15313000
Shareholding ratioCurrentQuarterInstant_No2MajorShareholdersMember0.1309
Number of shares heldCurrentQuarterInstant_No3MajorShareholdersMember6608000
Shareholding ratioCurrentQuarterInstant_No3MajorShareholdersMember0.0565
Number of shares heldCurrentQuarterInstant_No4MajorShareholdersMember3390000
Shareholding ratioCurrentQuarterInstant_No4MajorShareholdersMember0.0290
Number of shares heldCurrentQuarterInstant_No5MajorShareholdersMember3113000
Shareholding ratioCurrentQuarterInstant_No5MajorShareholdersMember0.0266
Number of shares heldCurrentQuarterInstant_No6MajorShareholdersMember2203000
Shareholding ratioCurrentQuarterInstant_No6MajorShareholdersMember0.0188
Number of shares heldCurrentQuarterInstant_No7MajorShareholdersMember1845000
Shareholding ratioCurrentQuarterInstant_No7MajorShareholdersMember0.0158
Number of shares heldCurrentQuarterInstant_No8MajorShareholdersMember1790000
Shareholding ratioCurrentQuarterInstant_No8MajorShareholdersMember0.0153
Number of shares heldCurrentQuarterInstant_No9MajorShareholdersMember1482000
Shareholding ratioCurrentQuarterInstant_No9MajorShareholdersMember0.0127
Number of shares heldCurrentQuarterInstant_No10MajorShareholdersMember1259000
Shareholding ratioCurrentQuarterInstant_No10MajorShareholdersMember0.0108
Number of shares heldCurrentQuarterInstant80782000
Shareholding ratioCurrentQuarterInstant0.6907
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithNoVotingRightsMember-
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember-
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember-
Number of voting rights issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember-
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember2379400
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember116934100
Number of voting rights issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember1169341
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember17684
Number of shares issued shares voting rightsCurrentQuarterInstant119331184
Number of voting rights issued shares voting rightsCurrentQuarterInstant1169341
Number of shares held in own name treasury shares etcCurrentQuarterInstant_Row1Member2379400
Number of shares held in others names treasury shares etcCurrentQuarterInstant_Row1Member-
Total number of shares held treasury shares etcCurrentQuarterInstant_Row1Member2379400
Shareholding ratio treasury shares etcCurrentQuarterInstant_Row1Member0.0199
Number of shares held in own name treasury shares etcCurrentQuarterInstant2379400
Number of shares held in others names treasury shares etcCurrentQuarterInstant-
Total number of shares held treasury shares etcCurrentQuarterInstant2379400
Shareholding ratio treasury shares etcCurrentQuarterInstant0.0199
Cash and depositsPrior1YearInstant80872000000JPY
Cash and depositsCurrentQuarterInstant76806000000JPY
Accounts receivable tradePrior1YearInstant22224000000JPY
Accounts receivable tradeCurrentQuarterInstant22799000000JPY
MerchandisePrior1YearInstant82700000000JPY
MerchandiseCurrentQuarterInstant86169000000JPY
SuppliesPrior1YearInstant327000000JPY
SuppliesCurrentQuarterInstant317000000JPY
Other caPrior1YearInstant19787000000JPY
Other caCurrentQuarterInstant20264000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2023-09-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-09-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-09-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-09-30pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-09-30pass